Reliable and precise patient-specific targeting to guide neuromodulation therapies.
Turing Medical Bullsai delivers efficient, accurate and effective patient-specific targeting for neuromodulation therapies. Our automated workflows streamline and enhance the use of advanced imaging for targeting – improving clinical outcomes while freeing up time for clinicians to engage in direct patient care.
Optimize neuromodulation therapies with precision and efficiency
Unlock the full potential of neuromodulation therapies with our advanced solutions. From precise image-based targeting to seamless integrations and automated workflows, we ensure consistent, personalized care that leads to shorter procedure times, higher success rates, and predictable outcomes. Experience fewer side effects and discover new targets through personalized brain mapping, revolutionizing patient care.
Revolutionary image-based targeting for precision.
Discover new targets for neuromodulation therapies.
Ensures high quality input by providing real-time feedback and final data QC score.
Caution: Bullsai Enhance is FDA 510(k) cleared as FIRMM. Federal law restricts this device to sale by or on the order of a physician.
Uses AI/ML to identify functional targets with advanced visualization.
Caution: Bullsai Identify is FDA 510(k) cleared. Federal law restricts this device to sale by or on the order of a physician.
Provides visual confirmation of accurate electrode placement.
This product has not been submitted to the Food and Drug Administration for review or clearance.
“We now understand that most neuropsychiatric disorders involve dysfunction in distributed brain networks or circuits. In response multiple neuromodulation approaches are being pursued as novel therapies to restore the balance of activity across affected brain networks. These emerging technologies all rely on advanced imaging to map structural and functional connections in individual patients in order to personalize the targeting of neuromodulation and measure its effects.”
“We now understand that most neuropsychiatric disorders involve dysfunction in distributed brain networks or circuits.
In response multiple neuromodulation approaches are being pursued as novel therapies to restore the balance of activity across affected brain networks. These emerging technologies all rely on advanced imaging to map structural and functional connections in individual patients in order to personalize the targeting of neuromodulation and measure its effects.”
Leo Sugrue, UCSF
Pioneering precision targeting for neuromodulation therapies
Turing Medical enhances neuromodulation therapies by efficiently integrating personalized and precise image-based targeting into existing clinical workflows. Our automated pipelines provide accurate and reliable patient-specific targeting and streamline pre-operative planning—saving time, improving patient outcomes, and minimizing off-target effects.
Learn more about how we are providing precision targeting for neuromodulation therapies.
Join our passionate team of physicians, neuroscientists, engineers and entrepreneurs.
We Are Transforming Neurological Treatment with AI.
